Skip to main content
Clinical Trials/JPRN-UMIN000014298
JPRN-UMIN000014298
Completed
未知

Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitors - Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitors

aka Kinen Clinic0 sites20 target enrollmentJune 18, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
aka Kinen Clinic
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 18, 2014
End Date
March 12, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
aka Kinen Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Type\-1 diabetes, diabetes due to a pancreatic disorder, or secondary diabetes due to conditions such as Cushing's syndrome and acromegaly (2\) Application of contraindications contained in the package insert (3\) Excessive alcohol consumption : mean daily intake of pure alcohol \>\=60g (4\) Pregnant women, women suspected of being pregnant, or lactating women (5\) Participation in the study is judged by the investigator or sub\-investigator as inappropriate for any other reason

Outcomes

Primary Outcomes

Not specified

Similar Trials